Monopar Therapeutics Inc (NASDAQ: MNPR) Not A Good Play Anymore?
Monopar Therapeutics Inc (MNPR) concluded trading on Thursday at a closing price of $32.66, with 19.49 million shares of worth about $636.54 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 940.96% during that period and on October 24, 2024 the price saw a […]
Monopar Therapeutics Inc (NASDAQ: MNPR): The Best-Of-Breed For Investing?
Currently, there are 12.95M common shares owned by the public and among those 6.37M shares have been available to trade. Insiders at the company have transacted a total of 25 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 17 of these insider trades were purchases, […]
Stick With Monopar Therapeutics Inc (MNPR). The Bull Are Alive And Well
Currently, there are 12.95M common shares owned by the public and among those 6.37M shares have been available to trade. Insiders at the company have transacted a total of 25 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 17 of these insider trades were purchases, […]
